NCT02727322View on ClinicalTrials.gov

Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

March 27, 2018

Study Completion Date

May 12, 2018

Conditions
Pelvic Organ Prolapse
Interventions
DRUG

Nitrofurantoin

Patients will receive nitrofurantoin 100mg once daily or a placebo. Pills will be identical.

DRUG

Placebo

Placebo

Trial Locations (2)

15213

Magee-Womens Hospital of UPMC, Pittsburgh

20007

Georgetown/MedStar Hospital Center, Washington D.C.

All Listed Sponsors
lead

Halina M Zyczynski, MD

OTHER

NCT02727322 - Nitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive Surgery | Biotech Hunter | Biotech Hunter